Sponsored

Surgery Is Associated With Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis

Using the NCDB, the authors evaluated outcomes for patients with T4a esophageal adenocarcinoma. Receipt of surgery, compared to definitive chemoradiotherapy, offered a significant benefit to overall survival (HR 0.26).  

0 comments

Leave a Reply

Log In

New to CTSNet? Sign Up